Newark-based Botox Company Files For IPO

Revance Therapeutics Inc. is raising money by going public.

Graphic credit: http://www.revance.com/
Graphic credit: http://www.revance.com/
Revance Therapeutics Inc. filed paperwork with the SEC on Thursday to raise $86 million through an initial public offering. 

The company is a clinical-stage biopharmaceutical business based in Newark, California that makes an enhanced botulinum toxin, which is also known as Botox. Its staff is researching ways to make botox a cream instead of an injection, according to its website.

The company is raising money to finance trials of this and other products. It raised $33 million during a round of series E financing back in April 2013.

The company plans to list on NASDAQ with the symbol RVNC. Cowen & Company as well as Piper Jaffray are co-book runners on the deal.

Revance Therapeutics Inc. was founded in 1999.  
Alison Avarez January 08, 2014 at 04:25 AM
Oh…injection moving to cream. It’s really nice and will be easy to use. But now my problem is I’m doing a Botox training course in The Aesthetic Advancements, Canada and if Botox cream comes do my training will get wasted? My time and money spend for training will get wasted?
Vanessa Castañeda (Editor) January 08, 2014 at 02:39 PM
Maybe. This product is in the research phase, from what I've read, so you have some time to assess the market.


More »
Got a question? Something on your mind? Talk to your community, directly.
Note Article
Just a short thought to get the word out quickly about anything in your neighborhood.
Share something with your neighbors.What's on your mind?What's on your mind?Make an announcement, speak your mind, or sell somethingPost something